Halil Zeki Tonbul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Halil Zeki Tonbul has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Hakan Ozer
Department of Nephrology Izmir Bakircay University İzmir Turkey
7 shared publications - Ismail Baloglu
Department of Nephrology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey
7 shared publications - Fethi Yönet
NECMETTİN ERBAKAN ÜNİVERSİTESİ, MERAM TIP FAKÜLTESİ, MERAM TIP PR
6 shared publications - Nedim Yılmaz Selcuk
Department of Nephrology, Department of Internal Medicine, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Turkey
6 shared publications - Yasin Öztürk
Department of Nephrology, Bülent Ecevit University, 67100 Zonguldak, Türkiye
6 shared publications - Kultigin Turkmen
Department of Nephrology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey
5 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 8, 164-173
Silent Brain Lesions in Chronic Kidney Disease: A Hidden Burden
Objective: Silent brain lesions (SBL), including silent brain infarction (SBI) and subcortical white matter lesions (SWML), are increasingly recognized as important radiological markers of cerebral small vessel disease. Patients with chronic kidney disease (CKD) may be at increased risk due to shared vascular and metabolic abnormalities. This study aimed to investigate the prevalence, radiological characteristics, and predictors of SBL in patients with CKD.Methods: This retrospective study included 276 patients with CKD who underwent brain magnetic resonance imaging (MRI) between March 2020 and March 2021. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m², and patients undergoing hemodialysis were included. MRI findings were classified as SBI, SWML, overt stroke, or no lesion. Silent brain lesions were defined as the presence of SBI and/or SWML in patients without a clinical history of stroke or focal neurological deficits. Clinical and laboratory data were analyzed, and independent predictors were determined using binary logistic regression.Results: Pathological MRI findings were detected in 177 patients (64.1%). Among them, 131 patients (74.0%) had SBL (73 SWML and 58 SBI), while 46 (26.0%) had overt stroke. Patients with SBL were older and had a higher prevalence of diabetes mellitus and hypertension compared with those with overt stroke. In multivariate logistic regression analysis, older age (OR: 1.073, 95% CI: 1.051–1.096; p < 0.001) and higher serum creatinine levels (OR: 1.306, 95% CI: 1.096–1.557; p = 0.003) were identified as independent predictors of SBL. Among patients with SBL, those with SWML had a longer duration of hemodialysis compared to those with SBI.Conclusion: Silent brain lesions are highly prevalent in patients with CKD. Older age and impaired renal function are independent predictors of SBL. These findings highlight the importance of cerebrovascular risk assessment in CKD patients, particularly in older individuals and those with advanced renal dysfunction.
- 8 September 2026
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 8, 164-173
Open AccessSilent Brain Lesions in Chronic Kidney Disease: A Hidden Burden
Objective: Silent brain lesions (SBL), including silent brain infarction (SBI) and subcortical white matter lesions (SWML), are increasingly recognized as important radiological markers of cerebral small vessel disease. Patients with chronic kidney disease (CKD) may be at increased risk due to shared vascular and metabolic abnormalities. This study aimed to investigate the prevalence, radiological characteristics, and predictors of SBL in patients with CKD.Methods: This retrospective study included 276 patients with CKD who underwent brain magnetic resonance imaging (MRI) between March 2020 and March 2021. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m², and patients undergoing hemodialysis were included. MRI findings were classified as SBI, SWML, overt stroke, or no lesion. Silent brain lesions were defined as the presence of SBI and/or SWML in patients without a clinical history of stroke or focal neurological deficits. Clinical and laboratory data were analyzed, and independent predictors were determined using binary logistic regression.Results: Pathological MRI findings were detected in 177 patients (64.1%). Among them, 131 patients (74.0%) had SBL (73 SWML and 58 SBI), while 46 (26.0%) had overt stroke. Patients with SBL were older and had a higher prevalence of diabetes mellitus and hypertension compared with those with overt stroke. In multivariate logistic regression analysis, older age (OR: 1.073, 95% CI: 1.051–1.096; p < 0.001) and higher serum creatinine levels (OR: 1.306, 95% CI: 1.096–1.557; p = 0.003) were identified as independent predictors of SBL. Among patients with SBL, those with SWML had a longer duration of hemodialysis compared to those with SBI.Conclusion: Silent brain lesions are highly prevalent in patients with CKD. Older age and impaired renal function are independent predictors of SBL. These findings highlight the importance of cerebrovascular risk assessment in CKD patients, particularly in older individuals and those with advanced renal dysfunction.
- Open Access
- 7 April 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 35 (2) , 163-170
Current Status of Kidney Replacement Therapy in Türkiye: A Summary of 2024 Turkish Society of Nephrology Registry Repor
Background: The Turkish Society of Nephrology registry annually collects nationwide data on hemodialysis, peritoneal dialysis (PD), and kidney transplantation. Registry findings are published annually; the current report marks the thirty-fifth year of data collection. The registry is in close collaboration with international registries. Methods: This study summarized data from the 2024 registry report and provided yearly trends in the management of end-stage kidney disease. Results: The number of patients receiving kidney replacement therapy continued to rise, reaching 92 461 individuals by the end of 2024. The prevalence and incidence of end-stage kidney disease were 1079.3 and 164 per million population, respec tively. Diabetes mellitus remained the leading cause of end-stage kidney disease. Hemodialysis was the most common type of treatment modality (70.4%), followed by kidney transplantation (25.4%) and PD (4.2%). Conclusion: End-stage kidney disease remains a major and expanding public health challenge in Türkiye. The kidney reg istry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem. Cite this article as: Seyahi N, Koçyiğit İ, Dinçer MT, et al. Current status of kidney replacement therapy in Türkiye: A summary of 2024 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2026;35(2):163-170.
- 7 April 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 35 (2) , 163-170
Open AccessCurrent Status of Kidney Replacement Therapy in Türkiye: A Summary of 2024 Turkish Society of Nephrology Registry Repor
Background: The Turkish Society of Nephrology registry annually collects nationwide data on hemodialysis, peritoneal dialysis (PD), and kidney transplantation. Registry findings are published annually; the current report marks the thirty-fifth year of data collection. The registry is in close collaboration with international registries. Methods: This study summarized data from the 2024 registry report and provided yearly trends in the management of end-stage kidney disease. Results: The number of patients receiving kidney replacement therapy continued to rise, reaching 92 461 individuals by the end of 2024. The prevalence and incidence of end-stage kidney disease were 1079.3 and 164 per million population, respec tively. Diabetes mellitus remained the leading cause of end-stage kidney disease. Hemodialysis was the most common type of treatment modality (70.4%), followed by kidney transplantation (25.4%) and PD (4.2%). Conclusion: End-stage kidney disease remains a major and expanding public health challenge in Türkiye. The kidney reg istry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem. Cite this article as: Seyahi N, Koçyiğit İ, Dinçer MT, et al. Current status of kidney replacement therapy in Türkiye: A summary of 2024 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2026;35(2):163-170.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1) , 7659188
Geographic and Clinical Patterns of Acute Kidney Injury Among Intensive Care Unit Patients in Turkey: A Subgroup Analysis of a National Prospective Cohort
Background: Acute kidney injury (AKI) is common among intensive care unit (ICU) patients and is associated with high morbidity and mortality. Data describing regional patterns of ICU‐associated AKI within a single country remain limited. This study aimed to provide a descriptive overview of regional variation in etiology, management, and outcomes of ICU patients with AKI in Turkey. Methods: This secondary analysis of a national, prospective, observational cohort included adult ICU patients with AKI. Demographic characteristics, etiological factors, AKI severity, kidney replacement therapy (KRT) practices, and 6‐month outcomes were evaluated across geographic regions using descriptive and exploratory approaches. Formal statistical comparisons across regions were not performed due to small subgroup sizes. Results: A total of 126 patients were included; 57.9% were male, with a median age of 69 years (IQR: 61.5–79). Prerenal factors were present in 80% of patients, frequently in combination with intrinsic causes such as sepsis and heart failure. More than half of patients (54.8%) had Stage 3 AKI. Overall outcomes were notably poor: cumulative survival rates were 46.4%, 27.1%, and 16.3% at 1, 3, and 6 months, respectively, a key finding of this study. Higher AKI stage, presence of sepsis, and greater inflammatory burden (based on SIRS criteria) were associated with poor outcomes in exploratory analyses. Variations in KRT modality were observed across regions, including greater use of continuous therapies in some centers. Due to limited sample size and small regional subgroups, comparisons across regions were not reliable. Conclusion: ICU‐associated AKI in Turkey is characterized by high disease severity and poor outcomes, consistent with findings reported worldwide. Observed differences in management practices across centers should be interpreted cautiously. Given the limited sample size and exploratory design, this study does not allow reliable assessment of geographic differences and should be considered hypothesis‐generating. Larger adequately powered studies are needed to better define regional variability and improve patient outcomes.
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1) , 7659188
Open AccessGeographic and Clinical Patterns of Acute Kidney Injury Among Intensive Care Unit Patients in Turkey: A Subgroup Analysis of a National Prospective Cohort
Background: Acute kidney injury (AKI) is common among intensive care unit (ICU) patients and is associated with high morbidity and mortality. Data describing regional patterns of ICU‐associated AKI within a single country remain limited. This study aimed to provide a descriptive overview of regional variation in etiology, management, and outcomes of ICU patients with AKI in Turkey. Methods: This secondary analysis of a national, prospective, observational cohort included adult ICU patients with AKI. Demographic characteristics, etiological factors, AKI severity, kidney replacement therapy (KRT) practices, and 6‐month outcomes were evaluated across geographic regions using descriptive and exploratory approaches. Formal statistical comparisons across regions were not performed due to small subgroup sizes. Results: A total of 126 patients were included; 57.9% were male, with a median age of 69 years (IQR: 61.5–79). Prerenal factors were present in 80% of patients, frequently in combination with intrinsic causes such as sepsis and heart failure. More than half of patients (54.8%) had Stage 3 AKI. Overall outcomes were notably poor: cumulative survival rates were 46.4%, 27.1%, and 16.3% at 1, 3, and 6 months, respectively, a key finding of this study. Higher AKI stage, presence of sepsis, and greater inflammatory burden (based on SIRS criteria) were associated with poor outcomes in exploratory analyses. Variations in KRT modality were observed across regions, including greater use of continuous therapies in some centers. Due to limited sample size and small regional subgroups, comparisons across regions were not reliable. Conclusion: ICU‐associated AKI in Turkey is characterized by high disease severity and poor outcomes, consistent with findings reported worldwide. Observed differences in management practices across centers should be interpreted cautiously. Given the limited sample size and exploratory design, this study does not allow reliable assessment of geographic differences and should be considered hypothesis‐generating. Larger adequately powered studies are needed to better define regional variability and improve patient outcomes.
- Open Access
- 29 July 2025
- Published by Dahiliye uzmanlari dernegi (DAHUDER) in DAHUDER Medical Journal
- Vol. 5 (3) , 89-95
In Which Hemodialysis Patients Have Covid-19 Cause Death More Often?
Background: We aimed to reveal the frequency, prognosis and factors affecting the prognosis of coronavirus disease 2019 (COVID-19) in hemodialysis patients. Methods: The frequency, symptoms (fever, throat ache, cough, weakness and diarrhea), laboratory findings (lymphocyte count and ratio, ferritin, c-reactive protein, d-dimer and fibrinogen), duration of hemodialysis, hemodialysis adequacy (determined by KtV Ure) and factors affecting patients who recovered or died of COVID-19 infection in chronic hemodialysis patients (n=730) in 5 different centers were investigated. Results: COVID-19 infection occurred in 141 of 730 patients in the 13-month period (19.3%), and twenty-nine died (20.5%). While the mean age of those who died was higher than those who recovered, the duration of hemodialysis treatment, gender distribution, and mean Kt/V were not different. The number of comorbidities was higher in patients who died than in those who recovered. Additional diseases such as type 2 diabetes mellitus, coronary artery disease, and heart failure were found at a higher rate in patients who died. Conclusion: Mortality rates in hemodialysis patients were found to be higher than in the general population, and similar to the general population, death was more common in patients with higher comorbidity and cardiovascular disease compared to patients who recovered. Since cardiovascular diseases are common in chronic hemodialysis patients, death from COVID-19 may be higher.
- 29 July 2025
- Published by Dahiliye uzmanlari dernegi (DAHUDER) in DAHUDER Medical Journal
- Vol. 5 (3) , 89-95
Open AccessIn Which Hemodialysis Patients Have Covid-19 Cause Death More Often?
Background: We aimed to reveal the frequency, prognosis and factors affecting the prognosis of coronavirus disease 2019 (COVID-19) in hemodialysis patients. Methods: The frequency, symptoms (fever, throat ache, cough, weakness and diarrhea), laboratory findings (lymphocyte count and ratio, ferritin, c-reactive protein, d-dimer and fibrinogen), duration of hemodialysis, hemodialysis adequacy (determined by KtV Ure) and factors affecting patients who recovered or died of COVID-19 infection in chronic hemodialysis patients (n=730) in 5 different centers were investigated. Results: COVID-19 infection occurred in 141 of 730 patients in the 13-month period (19.3%), and twenty-nine died (20.5%). While the mean age of those who died was higher than those who recovered, the duration of hemodialysis treatment, gender distribution, and mean Kt/V were not different. The number of comorbidities was higher in patients who died than in those who recovered. Additional diseases such as type 2 diabetes mellitus, coronary artery disease, and heart failure were found at a higher rate in patients who died. Conclusion: Mortality rates in hemodialysis patients were found to be higher than in the general population, and similar to the general population, death was more common in patients with higher comorbidity and cardiovascular disease compared to patients who recovered. Since cardiovascular diseases are common in chronic hemodialysis patients, death from COVID-19 may be higher.
- Open Access
- 20 June 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (2) , 99-102
How did the COVID-19 pandemic period affect the patients on the cadaver waiting list? A single-center experience
Aims: During the COVID-19 pandemic, kidney transplantations have decreased worldwide and in Turkiye. This study aimed to explore the expected increase in the number of patients on the cadaver waiting list and the factors influencing this outcome. Methods: We analyzed data from kidney transplant candidates during the pandemic period, focusing on mortality rates, causes of death, and patient behavior, such as attendance to routine transplant polyclinic visits. Results: Although an increase in the number of patients on the cadaver waiting list was expected, a decrease was reported in some centers. Mortality rates were higher in kidney transplant candidates due to COVID-19, but the highest death rate was still attributed to cardiovascular diseases. Additionally, the number of patients attending routine transplant polyclinic visits decreased due to fear of infection. Conclusion: The expected increase in patients on the cadaver waiting list was not observed, likely due to higher mortality rates and decreased clinic visits during the pandemic. The dilemma of transplantation and infection during the pandemic is a challenging issue, requiring careful follow-up in experienced centers.
- 20 June 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (2) , 99-102
Open AccessHow did the COVID-19 pandemic period affect the patients on the cadaver waiting list? A single-center experience
Aims: During the COVID-19 pandemic, kidney transplantations have decreased worldwide and in Turkiye. This study aimed to explore the expected increase in the number of patients on the cadaver waiting list and the factors influencing this outcome. Methods: We analyzed data from kidney transplant candidates during the pandemic period, focusing on mortality rates, causes of death, and patient behavior, such as attendance to routine transplant polyclinic visits. Results: Although an increase in the number of patients on the cadaver waiting list was expected, a decrease was reported in some centers. Mortality rates were higher in kidney transplant candidates due to COVID-19, but the highest death rate was still attributed to cardiovascular diseases. Additionally, the number of patients attending routine transplant polyclinic visits decreased due to fear of infection. Conclusion: The expected increase in patients on the cadaver waiting list was not observed, likely due to higher mortality rates and decreased clinic visits during the pandemic. The dilemma of transplantation and infection during the pandemic is a challenging issue, requiring careful follow-up in experienced centers.
- Open Access
- 15 April 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 34 (2) , 141-148
Current Status of Kidney Replacement Therapy in Türkiye: A Summary of 2023 Turkish Society of Nephrology Registry Report
Background: Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis (PD), and transplan tation annually. Registry reports are printed every year as a booklet, and this is the 34th year of the registry reports. The registry is in close collaboration with international registries. Methods: In this paper, we summarized data from the 2023 registry report and provided yearly trends for managing end stage kidney disease. Results: The number of patients on kidney replacement therapy (KRT) increased; at the end of 2023, 89 527 patients were on KRT. The prevalence and incidence of end-stage kidney disease were 1048.7 and 159.8 per million population, respec tively. Diabetes was the most common cause of end-stage kidney disease. Hemodialysis (70.88%) was the most common type of treatment modality, followed by transplantation (25.01%) and PD (4.11%). Conclusion: End-stage kidney disease is a critical and growing health problem for our country. The kidney registry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem. Cite this article as: Seyahi N, Koçyi#it ", Eren N, et!al. Current Status of Kidney Replacement Therapy in Türkiye: A Summary of 2023 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2025;34(2):141-148.
- 15 April 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 34 (2) , 141-148
Open AccessCurrent Status of Kidney Replacement Therapy in Türkiye: A Summary of 2023 Turkish Society of Nephrology Registry Report
Background: Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis (PD), and transplan tation annually. Registry reports are printed every year as a booklet, and this is the 34th year of the registry reports. The registry is in close collaboration with international registries. Methods: In this paper, we summarized data from the 2023 registry report and provided yearly trends for managing end stage kidney disease. Results: The number of patients on kidney replacement therapy (KRT) increased; at the end of 2023, 89 527 patients were on KRT. The prevalence and incidence of end-stage kidney disease were 1048.7 and 159.8 per million population, respec tively. Diabetes was the most common cause of end-stage kidney disease. Hemodialysis (70.88%) was the most common type of treatment modality, followed by transplantation (25.01%) and PD (4.11%). Conclusion: End-stage kidney disease is a critical and growing health problem for our country. The kidney registry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem. Cite this article as: Seyahi N, Koçyi#it ", Eren N, et!al. Current Status of Kidney Replacement Therapy in Türkiye: A Summary of 2023 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2025;34(2):141-148.
- Open Access
- 30 April 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (2) , 97-101
Acute cholestatic hepatitis due to infectious mononucleosis: A case report
Cholestatic hepatitis is a rare complication of acute Epstein-Barr virus (EBV) infection. Here, we presented a case of acute cholestatic hepatitis secondary to acute infectious mononucleosis, who presented with complaints of abdominal pain, yellowing of the eyes and body, itching, widespread body pain, fever, nausea and vomiting. It was emphasized that EBV infection should also be considered in the differential diagnosis of cholestatic hepatitis etiology.
- 30 April 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (2) , 97-101
Open AccessAcute cholestatic hepatitis due to infectious mononucleosis: A case report
Cholestatic hepatitis is a rare complication of acute Epstein-Barr virus (EBV) infection. Here, we presented a case of acute cholestatic hepatitis secondary to acute infectious mononucleosis, who presented with complaints of abdominal pain, yellowing of the eyes and body, itching, widespread body pain, fever, nausea and vomiting. It was emphasized that EBV infection should also be considered in the differential diagnosis of cholestatic hepatitis etiology.
- Open Access
- 12 December 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (6) , 1863-1869
Individualized hemodialysis: Is similar hemodialysis adequacy possible using less water?
Background and aim: There are over 60,000 hemodialysis (HD) patients in Türkiye, and the number of patients is increasing yearly. Dialysate flow rate (Qd) is a factor in HD adequacy. Approximately 150 L of water are consumed per session to prepare the dialysate. We aimed to investigate whether HD effectiveness can be achieved at a low Qd in different patient groups for the purpose of saving water. Materials and methods: This prospective study included 81 HD patients from 2 centers. The patients underwent an aggregate total of 486 HD sessions, including 3 sessions at a Qd of 500 mL/min and 3 sessions at a Qd of 300 mL/min for each patient. We used online Kt/V readings recorded at the end of each dialysis session to compare the effectiveness of these 2 types of HD session performed at a different Qd. Results: The online Kt/V readings were similar between the standard (500) and low (300) Qd HD (1.51 ∓ 0.41 and 1.49 ∓ 0.44, respectively, p = 0.069). In the subgroup analyses, men had higher online Kt/V values at the standard Qd compared to the low Qd (1.35 ∓ 0.30 and 1.30 ∓ 0.32, respectively, p = 0.019), but the Kt/V values were not different for women. While the low Qd did not reduce online Kt/V in patients using small surface area dialysis membranes (1.75 ∓ 0.35 for 300 Qd and 1.75 ∓ 0.32 for 500 Qd, p = 0.931), it was associated with reduced online Kt/V in patients using large surface area dialysis membranes (1.12 ∓ 0.25 for 300 Qd and 1.17 ∓ 0.24 for 500 Qd, p = 0.006). The low Qd did not result in differences in online Kt/V among low-weight patients. However, online Kt/V values were better with the standard Qd in patients weighing 65 kg and above. Conclusion: In our study, dialysis adequacy at a reduced dialysate flow was not inferior for women, patients with low body weight, or patients using small surface area membranes. Individualized HD at a reduced Qd of 300 mL/min in eligible patients can save 48 L of water per HD session and an average of 7500 L of water per year.
- 12 December 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (6) , 1863-1869
Open AccessIndividualized hemodialysis: Is similar hemodialysis adequacy possible using less water?
Background and aim: There are over 60,000 hemodialysis (HD) patients in Türkiye, and the number of patients is increasing yearly. Dialysate flow rate (Qd) is a factor in HD adequacy. Approximately 150 L of water are consumed per session to prepare the dialysate. We aimed to investigate whether HD effectiveness can be achieved at a low Qd in different patient groups for the purpose of saving water. Materials and methods: This prospective study included 81 HD patients from 2 centers. The patients underwent an aggregate total of 486 HD sessions, including 3 sessions at a Qd of 500 mL/min and 3 sessions at a Qd of 300 mL/min for each patient. We used online Kt/V readings recorded at the end of each dialysis session to compare the effectiveness of these 2 types of HD session performed at a different Qd. Results: The online Kt/V readings were similar between the standard (500) and low (300) Qd HD (1.51 ∓ 0.41 and 1.49 ∓ 0.44, respectively, p = 0.069). In the subgroup analyses, men had higher online Kt/V values at the standard Qd compared to the low Qd (1.35 ∓ 0.30 and 1.30 ∓ 0.32, respectively, p = 0.019), but the Kt/V values were not different for women. While the low Qd did not reduce online Kt/V in patients using small surface area dialysis membranes (1.75 ∓ 0.35 for 300 Qd and 1.75 ∓ 0.32 for 500 Qd, p = 0.931), it was associated with reduced online Kt/V in patients using large surface area dialysis membranes (1.12 ∓ 0.25 for 300 Qd and 1.17 ∓ 0.24 for 500 Qd, p = 0.006). The low Qd did not result in differences in online Kt/V among low-weight patients. However, online Kt/V values were better with the standard Qd in patients weighing 65 kg and above. Conclusion: In our study, dialysis adequacy at a reduced dialysate flow was not inferior for women, patients with low body weight, or patients using small surface area membranes. Individualized HD at a reduced Qd of 300 mL/min in eligible patients can save 48 L of water per HD session and an average of 7500 L of water per year.
- 22 November 2023
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 28 (2) , 234-239
Overlooked factor in the etiology of pruritus in hemodialysis patients: Ultrafiltration volume
Introduction: This study investigated the relationship between ultrafiltration (UF) volume and pruritus severity based on the idea that skin perfusion and inflammatory changes occur in dialysis patients with high UF volume.Materials and Methods: This observational study included 392 patients. Patients filled out the Numerical Rating Scale, Verbal Rating Scale, and Visual Analogue Scale, showing the severity of pruritis. UF volumes in the last 12 sessions were recorded and averaged.Results: The rate of patients with pruritis was between 59.4% and 67.5% in the three scales. In three pruritis scales, the severity of pruritis, age, body mass index (BMI), UF volume, and UF volume/body weight ratio were positively correlated. UF volume/body weight ratio, age, and BMI were independent predictors of pruritis severity.Conclusion: Limiting interdialytic weight gain may be an important treatment approach in pruritus control.
- 22 November 2023
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 28 (2) , 234-239
Overlooked factor in the etiology of pruritus in hemodialysis patients: Ultrafiltration volume
Introduction: This study investigated the relationship between ultrafiltration (UF) volume and pruritus severity based on the idea that skin perfusion and inflammatory changes occur in dialysis patients with high UF volume.Materials and Methods: This observational study included 392 patients. Patients filled out the Numerical Rating Scale, Verbal Rating Scale, and Visual Analogue Scale, showing the severity of pruritis. UF volumes in the last 12 sessions were recorded and averaged.Results: The rate of patients with pruritis was between 59.4% and 67.5% in the three scales. In three pruritis scales, the severity of pruritis, age, body mass index (BMI), UF volume, and UF volume/body weight ratio were positively correlated. UF volume/body weight ratio, age, and BMI were independent predictors of pruritis severity.Conclusion: Limiting interdialytic weight gain may be an important treatment approach in pruritus control.
- Open Access
- 29 April 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (2) , 124-134
Factors Affecting Kidney Functions in One-Year Follow-up After COVID-19 in Kidney Transplant Patients
Background Coronavirus disease (COVID-19) is more severe, and mortality is higher in kidney transplantation (KTx) patients; it is still unclear how renal functions progress and the conditions affecting renal functions in the post-COVID-19 period. We aimed to investigate the changes in kidney functions and the factors affecting this change after COVID-19. Material and Methods Forty-one kidney transplantation patients who were hospitalised for COVID-19 were included in this retrospective study. The patient's personal information, examination, and treatment information regarding their hospitalisation and follow-ups were obtained from the hospital system. Results Patients with elevated serum creatinine in the first year post-COVID had higher baseline proteinuria and systemic immune inflammation index (SII). Proteinuria increased more in patients with a long transplantation period, hypertension, high basal creatinine, and SII. Also, proteinuria was higher in patients who developed AKI during the COVID period. In addition, baseline SII was an independent predictor of the change in serum creatinine and proteinuria. Conclusions We found that patients with signs of increased inflammation, such as high SII were more fragile regarding renal functions. Therefore, the post-COVID-19 follow-up process of KTx patients with COVID-19 should be individualised.
- 29 April 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (2) , 124-134
Open AccessFactors Affecting Kidney Functions in One-Year Follow-up After COVID-19 in Kidney Transplant Patients
Background Coronavirus disease (COVID-19) is more severe, and mortality is higher in kidney transplantation (KTx) patients; it is still unclear how renal functions progress and the conditions affecting renal functions in the post-COVID-19 period. We aimed to investigate the changes in kidney functions and the factors affecting this change after COVID-19. Material and Methods Forty-one kidney transplantation patients who were hospitalised for COVID-19 were included in this retrospective study. The patient's personal information, examination, and treatment information regarding their hospitalisation and follow-ups were obtained from the hospital system. Results Patients with elevated serum creatinine in the first year post-COVID had higher baseline proteinuria and systemic immune inflammation index (SII). Proteinuria increased more in patients with a long transplantation period, hypertension, high basal creatinine, and SII. Also, proteinuria was higher in patients who developed AKI during the COVID period. In addition, baseline SII was an independent predictor of the change in serum creatinine and proteinuria. Conclusions We found that patients with signs of increased inflammation, such as high SII were more fragile regarding renal functions. Therefore, the post-COVID-19 follow-up process of KTx patients with COVID-19 should be individualised.